bromocriptine

(redirected from Bromocriptine mesylate)
Also found in: Dictionary, Medical.
Related to Bromocriptine mesylate: hyperprolactinemia, Cabergoline

bromocriptine

[‚brō·mō′krip‚tēn]
(organic chemistry)
C32H40BrN5O5 A polypeptide alkaloid that is a derivative of the ergotoxin group of ergot alkaloids and is a dopamine receptor agonist.
Mentioned in ?
References in periodicals archive ?
They received daily add-on bromocriptine mesylate for 52 weeks, and the analysis was performed using intent to treat modified and evaluable per protocol basis.
Effect of bromocriptine mesylate in 22 obese T2DM subjects was studied in a double-blinded trial lasting 16 weeks.
Bromocriptine mesylate monotherapy significantly reduced HbA1c from 8.
in 1999 conducted 24-week randomized trials of quick release preparation of bromocriptine mesylate in type 2 diabetic patients in a double-blind fashion.
An Indian study to evaluate the safety and efficacy of bromocriptine mesylate was conducted by Ramteke et al.
6] The present study was undertaken to evaluate the efficacy of bromocriptine mesylate in maximal recommended dose as an add-on therapy to two oral antidiabetic drugs.
To study the efficacy of bromocriptine mesylate as an add-on therapy in patients with T2DM inadequately controlled on two oral antidiabetic drugs.
Efficacy of bromocriptine mesylate was assessed by measuring FBS (mg/dL), PPBS (mg/dL) and HbA1c (%) at 0, 6 and 12 weeks.
After 6 weeks of bromocriptine mesylate add-on therapy, FBS, PPBS, and HbA1c showed a mean change of -19.
All 50 patients were continued on bromocriptine mesylate add-on therapy until 12 weeks with further significant reduction in all three parameters (P < 0.